News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Room to Grow
Cointime·2024/06/04 14:58
Warren Buffett's Berkshire Hathaway did crash 99% ...against Bitcoin since 2015
Cointelegraph·2024/06/04 14:49
This Is What’s Happening in DeFi: dYdX, 3Jane, MakerDAO, and More
BeInCrypto·2024/06/04 14:37
Only 9% of Algorand (ALGO) Investors Are in Profit Amid Strong Holder Conviction
BeInCrypto·2024/06/04 14:37
Thailand Approves First Spot Bitcoin Exchange-Traded Fund (ETF)
Dailycoin·2024/06/04 14:25
4 Biggest Crypto Predictions for June 2024
BeInCrypto·2024/06/04 14:19
Here’s How Much Spot Bitcoin ETFs Have Contributed to BlackRock and Fidelity’s 2024 Inflows
Bitcoin ETFs contribute 26% of BlackRock’s 2024 inflows and 56% of Fidelity’s, reflecting growing institutional interest in the asset.
Cryptopotato·2024/06/04 13:49
Polkadot (DOT) Ecosystem Recap: The Recent Advancements
Pokadot launched an educational program in Singapore: check out for details.
Cryptopotato·2024/06/04 13:49
StarkWare plans to bring ZK scaling to Bitcoin alongside Ethereum
Quick Take Starknet developer StarkWare plans to bring its zero-knowledge tech to Bitcoin, simultaneously scaling the network alongside Ethereum. The decision follows a technical proposal known as OP_CAT — providing the framework required to bring STARK scaling to Bitcoin.
The Block·2024/06/04 13:47
Polygon Labs acquires Toposware, pushing total ZK investment to $1B
Cointelegraph·2024/06/04 13:46
Flash
22:23
According to the Chinese Ambassador to Canada, Canada's annual crude oil supply to China is expected to increase from 15.5 million tons last year to nearly 22 million tons.This potential growth reflects the possibility of further deepening cooperation between China and Canada in the energy sector. If achieved, it would significantly increase Canada's share of crude oil in the Chinese market and have a certain impact on the global energy trade pattern.
22:23
Viridian Therapeutics announced that its innovative drug Lumvoa™ (generic name: veligrotug-vvze) has been approved by the U.S. Food and Drug Administration (FDA) and officially launched for the treatment of Thyroid Eye Disease (TED).This approval marks a significant advancement for Viridian Therapeutics in the field of ophthalmic treatments. Lumvoa™ is a biologic targeting specific targets, and its approval offers a new treatment option for patients with thyroid eye disease. Thyroid eye disease is an autoimmune disorder associated with thyroid dysfunction, causing symptoms such as eye protrusion, double vision, impaired vision, and others, which severely impact patients' quality of life. The launch of this new drug is expected to address unmet medical needs in this disease area.The company stated it will promptly initiate the commercialization process for Lumvoa™ in the United States, ensuring that the drug can benefit patients in need as soon as possible. This approval is based on multiple clinical study data, which demonstrate the effectiveness and safety of the therapy in improving disease signs and symptoms.
22:10
Base mainnet experiences its second outage in two days and has now resumed.Odaily reported that Base experienced a mainnet block production anomaly for the second time in two days. According to the official status page, the incident occurred at 15:33 UTC, with the team confirming the issue and resuming block production at 16:11. Base stated that node operators need to restart Base mainnet nodes to complete resynchronization. This incident displayed symptoms similar to the previous day’s outage. On Thursday, an abnormal block caused the Sequencer to be unable to continue constructing new blocks, resulting in the network being down for about two hours. Although user funds were not affected, withdrawal services were temporarily interrupted. The official announcement indicated that the latest failure also manifested as a chain halt, sharing key characteristics with the previous day’s incident. The network has now resumed operation.
News